C4 Therapeutics, Inc. (CCCC) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: C4 Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
C4 Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$557M, a 29.3% decline year-over-year.

Retained Earnings (Accumulated Deficit), Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	-$557M	-$126M	-29.3%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	-$528M	-$132M	-33.5%	Dec 31, 2023	10-Q	2024-05-08
Q3 2023	-$494M	-$135M	-37.6%	Sep 30, 2023	10-Q	2023-11-01
Q2 2023	-$467M	-$140M	-42.8%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	-$431M	-$131M	-43.9%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	-$396M	-$128M	-47.9%	Dec 31, 2022	10-K	2024-02-22
Q3 2022	-$359M	-$107M	-42.3%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	-$327M	-$99.4M	-43.7%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	-$299M	-$94.5M	-46.2%	Mar 31, 2022	10-Q	2022-05-05
Q4 2021	-$268M	-$83.9M	-45.6%	Dec 31, 2021	10-K	2023-02-23
Q3 2021	-$252M	-$90M	-55.6%	Sep 30, 2021	10-Q	2021-11-10
Q2 2021	-$227M			Jun 30, 2021	10-Q	2021-08-11
Q1 2021	-$205M			Mar 31, 2021	10-Q	2021-05-13
Q4 2020	-$184M	-$66.3M	-56.5%	Dec 31, 2020	10-K	2022-02-24
Q3 2020	-$162M			Sep 30, 2020	10-Q	2020-11-12
Q4 2019	-$117M			Dec 31, 2019	10-K	2021-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.